Business models: A challenging agenda C Baden-Fuller, V Mangematin Strategic Organization 11 (4), 418-427, 2013 | 808 | 2013 |
From recipe to dinner: business model portfolios in the European biopharmaceutical industry V Sabatier, V Mangematin, T Rousselle Long Range Planning 43 (2-3), 431-447, 2010 | 454 | 2010 |
PhD job market: professional trajectories and incentives during the PhD V Mangematin Research policy 29 (6), 741-756, 2000 | 429 | 2000 |
What kind of knowledge can a firm absorb? V Mangematin, L Nesta International Journal of Technology Management 18 (3-4), 149-172, 1999 | 319 | 1999 |
Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry J Zhang, C Baden-Fuller, V Mangematin Research policy 36 (4), 515-528, 2007 | 315 | 2007 |
Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France V Mangematin, S Lemarié, JP Boissin, D Catherine, F Corolleur, ... Research Policy 32 (4), 621-638, 2003 | 306 | 2003 |
University technology transfer offices: The search for identity to build legitimacy C O’kane, V Mangematin, W Geoghegan, C Fitzgerald Research Policy 44 (2), 421-437, 2015 | 294 | 2015 |
When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry V Sabatier, A Craig-Kennard, V Mangematin Technological Forecasting and Social Change 79 (5), 949-962, 2012 | 280 | 2012 |
Technological agglomeration and the emergence of clusters and networks in nanotechnology DKR Robinson, A Rip, V Mangematin Research policy 36 (6), 871-879, 2007 | 270 | 2007 |
Orchestrating innovation with user communities in the creative industries G Parmentier, V Mangematin Technological forecasting and social change 83, 40-53, 2014 | 253 | 2014 |
Collaboration, creativity and rewards: why and how scientists collaborate G Laudel International Journal of Technology Management 22 (7-8), 762-781, 2001 | 235 | 2001 |
Profile of public laboratories, industrial partnerships and organisation of R & D: the dynamics of industrial relationships in a large research organisation PB Joly, V Mangematin Research policy 25 (6), 901-922, 1996 | 187 | 1996 |
Understanding the emergence and deployment of “nano” S&T B Bozeman, P Laredo, V Mangematin Research policy 36 (6), 807-812, 2007 | 176 | 2007 |
Disassembly and reassembly: An introduction to the Special Issue on digital technology and creative industries V Mangematin, J Sapsed, E Schüßler Technological Forecasting and Social Change 83, 1-9, 2014 | 160 | 2014 |
Is the creation and development of biotech SMEs localised? Conclusions drawn from the French case S Lemarié, V Mangematin, A Torre Small business economics 17 (1), 61-76, 2001 | 159 | 2001 |
Profiles of academic activities and careers: Does gender matter? An analysis based on French life scientist CVs M Sabatier, M Carrere, V Mangematin The Journal of Technology Transfer 31, 311-324, 2006 | 142 | 2006 |
Seed accelerators and the speed of new venture creation J Stayton, V Mangematin The Journal of Technology Transfer 44, 1163-1187, 2019 | 139 | 2019 |
The future of nanotechnologies V Mangematin, S Walsh Technovation 32 (3-4), 157-160, 2012 | 139 | 2012 |
La confiance: approches économiques et sociologiques C Thuderoz, V Mangematin, D Harrisson G. Morin, 1999 | 132 | 1999 |
Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France CDF Corolleur, M Carrere, V Mangematin Research Policy 33 (4), 631-642, 2004 | 131 | 2004 |